Skip to content

Contact Us: 1-518-583-0095    Follow Criterium on LinkedIn    We’re Hiring… Join Our Team!

Request a Proposal
Criterium
  • Home
  • Services
    • Clinical Trial Services
    • Client Services
    • IVR/IWR & ePRO
    • Criterium Technology
    • Retrospective Studies
    • CORE Science Solutions
  • Oncology Consortia
    • Breast Cancer (ABRCC)
    • GI Cancer (AGICC)
    • Myeloma (AMyC)
    • Thoracic Oncology (ATOMIC)
    • Genitourinary Cancer (AURIC)
  • Therapeutic Areas
  • Resources
    • Case Studies
    • Publications & Abstracts
    • Videos & Podcasts
    • Whitepapers
    • Newsletter Archives
    • About Clinical Trials
  • News & Blog
  • About Us
    • The Criterium Edge
    • Executive Team
    • History
    • International Reach
  • Contact Us
    • Site Registration
    • Careers
  • Home
  • Services
    • Clinical Trial Services
    • Client Services
    • IVR/IWR & ePRO
    • Criterium Technology
    • Retrospective Studies
    • CORE Science Solutions
  • Oncology Consortia
    • Breast Cancer (ABRCC)
    • GI Cancer (AGICC)
    • Myeloma (AMyC)
    • Thoracic Oncology (ATOMIC)
    • Genitourinary Cancer (AURIC)
  • Therapeutic Areas
  • Resources
    • Case Studies
    • Publications & Abstracts
    • Videos & Podcasts
    • Whitepapers
    • Newsletter Archives
    • About Clinical Trials
  • News & Blog
  • About Us
    • The Criterium Edge
    • Executive Team
    • History
    • International Reach
  • Contact Us
    • Site Registration
    • Careers
×

Principal Investigators in the News – November 2025

  1. Home
  2. Consortia
  3. Oncology Consortia
  4. Principal Investigators in the News – November 2025

Principal Investigators in the News – November 2025

  • Posted on December 15, 2025
  • In Consortia, Oncology Consortia

Reviewing Treatment Study Outcomes for Metastatic Hormone-sensitive Prostate Cancer 

Dr. Mike Cusnir

Mike Cusnir, M.D. from Criterium’s Academic GI Cancer Consortium (AGICC) and Mount Sinai Comprehensive Cancer Center discusses research and treatments for patients with metastatic hormone-sensitive prostate cancer
Learn more about the study outcomes and how they may affect treatment

Prevalence of Lung Cancer in Women

Dr. Jeremy Cetnar

Jeremy Cetnar, M.D. from Criterium’s Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC) and Oregon Health & Science University provides insights on lung cancer’s prevalence in women.
Read the article from the OHSU Center for Women’s Health

FacebookTwitterLinkedIn

Recommended Posts

Oncology News from Leading Researchers – July 2026
Oncology News from Leading Researchers – June 2026
Oncology News from Leading Researchers – May 2026

Recent Articles

2026 Skin Cancer Facts and Statistics

Oncology News from Leading Researchers – July 2026

7 Questions to Ask When Choosing a CRO for Your Clinical Trial

Oncology News from Leading Researchers – June 2026

Rare Disease Research Updates

Subscribe to our Newsletter

(We are GDPR compliant, as your info is for our internal use only. We never sell or share your info, ever.)

  • This field is for validation purposes and should be left unchanged.

Get to Know Us!

Request a Proposal

Contact Us

Criterium Headquarters
358 Broadway, Suite 201
Saratoga Springs, NY 12866

Phone: 1-518-583-0095
Fax: 1-518-583-0394

Follow Criterium on LinkedInFollow Us on LinkedIn

About Us

The Criterium Edge

Executive Team

History

International Reach

Careers

Services

Clinical Trial Services

Client Services

IVR/IWR & ePRO

Criterium Technology

CORE Science Solutions

Our Experience

Oncology Consortia

Therapeutic Areas

Privacy Policy    |   Sitemap   |   Clinical Site Registration   |   CRA Registration

© COPYRIGHT CRITERIUM, INC. 2024. ALL RIGHTS RESERVED.

Manage Cookie Consent
We use cookies to optimize our website.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View Preferences
{title} {title} {title}
Manage Cookie Consent
We use cookies to optimize our website.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View Preferences
{title} {title} {title}